The Role of FimH in ExPEC Translocation

FimH 在 ExPEC 易位中的作用

基本信息

  • 批准号:
    9165737
  • 负责人:
  • 金额:
    $ 23.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-20 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary The movement of enteric bacteria from the intestine to the blood and other organs is called translocation, a concept recognized clinically in the 1960s and defined experimentally in the 1980s. Translocation is a major precursor to the development of life-threatening bacteremia and sepsis, with a compromised immune system being a dominant risk factor. A significant cause of gut-derived sepsis is ExPEC, which clinically is the most frequently isolated Gram-negative pathogen from bacteremic patients. ExPEC is often multi-drug resistant, and there is evidence that such strains may be chronic colonizers of the GI tract. There is no vaccine. The mechanism by which ExPEC translocates out of the intestine has not been determined, and the bacterial factors needed for this process remain unknown. This funding period proposes to determine the importance of the pilus tip adhesin FimH in translocation. Preliminary data presented here suggests FimH is required for clinical strains of ExPEC to bind, invade, and pass through a transformed intestinal cell line. Hypothesizing that FimH is necessary for translocation in human hosts, we test here the requirements of FimH for passage through human intestinal enteroids and translocation in a murine model of leukopenia. In addition, we use these model systems, which our laboratory developed, to determine the molecular requirements of FimH-mediated translocation through enterocytes, the importance of FimH in globally circulating lineages of ExPEC, and if distinct FimH alleles dictate the efficiency of translocation. This work will determine if FimH is a viable target for preventing gut-derived sepsis in high-risk patients.
项目摘要 肠道细菌从肠道到血液和其他器官的运动被称为 易位,这是一个在20世纪60年代临床上认识到的概念, 80年代易位是危及生命的菌血症发展的主要前兆, 脓毒症,免疫系统受损是主要风险因素。的重要原因 肠源性脓毒症是ExPEC,临床上最常见的革兰氏阴性菌 从菌血症病人身上提取的病原体ExPEC通常具有多重耐药性,有证据表明 这些菌株可能是胃肠道的慢性定植者。没有疫苗。机制 ExPEC从肠道转移出来的方式尚未确定, 这一进程所需的因素仍然未知。本供资期建议确定 菌毛尖端粘附素FimH在易位中的重要性。 本文提供的初步数据表明,FimH是ExPEC临床菌株结合所需的, 侵入并通过转化的肠细胞系。假设FimH是必要的 对于人类宿主中的易位,我们在这里测试FimH通过 人肠上皮细胞和白细胞减少症小鼠模型易位。我们还使用 这些模型系统,我们的实验室开发,以确定分子的要求, FimH介导的通过肠上皮细胞的易位,FimH在全球的重要性, ExPEC的循环谱系,以及不同的FimH等位基因是否决定易位的效率。 这项工作将确定FimH是否是预防高危患者肠源性脓毒症的可行靶点。 患者

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANTHONY W MARESSO其他文献

ANTHONY W MARESSO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANTHONY W MARESSO', 18)}}的其他基金

Sugar regulation of EHEC virulance
EHEC毒力的糖调节
  • 批准号:
    10661099
  • 财政年份:
    2022
  • 资助金额:
    $ 23.78万
  • 项目类别:
Sugar regulation of EHEC virulance
EHEC毒力的糖调节
  • 批准号:
    10599476
  • 财政年份:
    2022
  • 资助金额:
    $ 23.78万
  • 项目类别:
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces
增强粘膜表面治疗潜力所需的噬菌体特性的机制见解
  • 批准号:
    10583463
  • 财政年份:
    2021
  • 资助金额:
    $ 23.78万
  • 项目类别:
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces
增强粘膜表面治疗潜力所需的噬菌体特性的机制见解
  • 批准号:
    10357968
  • 财政年份:
    2021
  • 资助金额:
    $ 23.78万
  • 项目类别:
Sugar regulation of EHEC virulence
肠出血性大肠杆菌毒力的糖调节
  • 批准号:
    10203813
  • 财政年份:
    2020
  • 资助金额:
    $ 23.78万
  • 项目类别:
Sugar regulation of EHEC virulence
肠出血性大肠杆菌毒力的糖调节
  • 批准号:
    10065360
  • 财政年份:
    2020
  • 资助金额:
    $ 23.78万
  • 项目类别:
The Genomics and Antagonism of Pathobiont Colonization
致病生物定植的基因组学和拮抗作用
  • 批准号:
    10160780
  • 财政年份:
    2019
  • 资助金额:
    $ 23.78万
  • 项目类别:
The Genomics and Antagonism of Pathobiont Colonization
致病生物定植的基因组学和拮抗作用
  • 批准号:
    10601129
  • 财政年份:
    2019
  • 资助金额:
    $ 23.78万
  • 项目类别:
Branched Chain Amino Acid Metabolism During Anthrax
炭疽病期间的支链氨基酸代谢
  • 批准号:
    9807632
  • 财政年份:
    2019
  • 资助金额:
    $ 23.78万
  • 项目类别:
The Genomics and Antagonism of Pathobiont Colonization
致病生物定植的基因组学和拮抗作用
  • 批准号:
    10396592
  • 财政年份:
    2019
  • 资助金额:
    $ 23.78万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.78万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了